KOPRANPharmaceuticals
Kopran Ltd — Quarterly Results & Earnings
₹108.04
-6.75%
Profit Growth YoY-234.42%Latest quarter
Sales Growth YoY-22.20%Latest quarter
Sales CAGR 5Y11.86%5 year compound
Profit CAGR 5Y12.38%5 year compound
📋
Quarterly Performance
YoY Profit Growth-234.42%
🔴 Significant decline
YoY Sales Growth-22.20%
🔴 Significant decline
OPM 5Y Average
13.33%Operating profit margin
EPS Growth 5Y
9.95%Interest Coverage
3.70Higher = safer debt servicing
ROE
7.64%ROCE
9.75%💡
Growth Analysis
Kopran Ltd reported YoY profit growth of -234.42% and revenue growth of -22.20% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 11.86% and profits at 12.38% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Kopran Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.